BAGUERA® C Cervical Disc Receives FDA Approval for One- and Two-Level Use
Spineart’s BAGUERA® C cervical disc has received FDA approval for one- and two-level cervical disc replacement in the United States, expanding the range of motion-preserving technologies available for appropriately selected patients. Supported by randomized clinical trials and 10-year follow-up data, the device adds another evidence-backed option for treating cervical disc disease while preserving motion at the affected level.
